Therapeutic Areas

XBiotech Has Conducted Extensive Clinical Research On Its True Human Antibodies

Clinical History

Explore XBiotech's completed clinical trials, offering a snapshot of key research milestones.

Area of Medicine
Investigational Agent
Indication
Phase I
Phase II
Phase III
Oncology

Bermekimab

Advanced Cancers

Oncology

Bermekimab

Leukemia

Oncology

Bermekimab

Metastatic Colorectal Cancer

Oncology

Bermekimab

Symptomatic Colorectal Cancer

Oncology

Vilamakitug

Pancreatic Cancer

Dermatology

Bermekimab

Atopic Dermatitis

Dermatology

Bermekimab

Acne Vulgaris

Dermatology

Bermekimab

Psoriasis

Dermatology

Bermekimab

Pyoderma Gangrenosum

Dermatology

Bermekimab

Hidradenitis Supperativa

Dermatology

Bermekimab

Atopic Dermatitis

Dermatology

Bermekimab

Hidradenitis Supperativa

Cardiovascular

Bermekimab

Restenosis

Pharmacokinetic

Lunlekitug

PK in Healthy Volunteers

Rheumatology

Vilamakitug

Rheumatoid Arthritis

Endocrinology

Bermekimab

Type 2 Diabetes

Infectious Disease

Omodenbamab

S. Aureus Bacteremia